Condition: Benign Thyroid Nodule · Sponsor: University Hospital, Ghent
The goal of this observational study is to learn if radiofrequency ablation (RFA), a minimally invasive thermoablation technique, can safely reduce symptoms and improve quality of life in adults with symptomatic benign thyroid nodules or autonomously functioning thyroid nodules. The main questions it aims to answer are: * Does RFA improve health-related quality of life (HRQoL) as measured by the ThyPRO-39 questionnaire? * Does RFA effectively reduce nodule volume and related symptoms (compressive or cosmetic)? Participants will: * Undergo a radiofrequency ablation procedure of the thyroid nodule performed under ultrasound guidance in an outpatient setting. * Complete quality of life questionnaires (ThyPRO-39) before treatment and at follow-up visits. Attend follow-up visits at 1, 3, 6, and 12 months with: * Ultrasound assessments of the thyroid nodule * Symptom and cosmetic scoring * Blood tests to monitor thyroid function * Safety checks for possible complications
This description comes directly from the study's public registry record.
Charlotte Harth, MD · +32 9 332 0450 · studies.vinrad@uzgent.be
Lien Van Cauwenberghe, MSc · +32 9 332 0450 · lien.vancauwenberghe@uzgent.be
Always discuss trial participation with your own doctor first.
| AZ Sint-Jan Brugge | Bruges, Belgium | Not Yet Recruiting |
| UZ Gent | Ghent, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07237373